Who
Cari Gallman
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Bristol-Myers Squibb.
In numbers
- Trades disclosed
- 84
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Oct 2023
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —4,559 at $0.00 | filing |
| 2 Oct 2026filed 5 Oct 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $143K2,332 at $61.15 | filing |
| 2 Oct 2026filed 5 Oct 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,559 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —1,061 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $35K543 at $65.31 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,061 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,061 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —1,061 at $0.00 | filing |
| 1 Aug 2026filed 4 Aug 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $35K543 at $65.31 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code M | —912 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —912 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —867 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,201 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —26,122 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —39,184 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code J | —102 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers SquibbPharmaceuticals | SEC FORM 4 Code F | $25K415 at $60.13 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —912 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —867 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,201 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.